Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 698)
Posted On: 01/04/2024 4:36:03 AM
Post# of 153771
Posted By: ohm20
Re: MGK_2 #140376
If the rise in HIV counts is due to release of HIV in reservoirs and near 100% receptor occupancy still exists then there would be no effect. It would actually help in emptying reservoirs sooner. If it's a rapid rise in CCR5 that leronlimab fails to bind then it could be a problem in a complete cure. What we don't know (but Cytodyn would) is if those blips do not occur after very long term use of leronlimab or not.

What they're looking at in AAV vector leronlimab is a functional cure which means below 200 copies per millimeter all the time. With the body itself producing leronlimab it would almost certainly mean greater than an equivalent 700mg dose so it should cover the rise in CCR5.













(10)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site